Jonathan Javitt

NRx Pharma Subsidiary HOPE Therapeutics Secures $30M to Buy Ketamine Clinics

HOPE Therapeutics, a subsidiary of Wilmington, Del.-headquartered NRx Pharmaceuticals (Nasdaq: NRXP), has secured a $30 million deal to fund its planned acquisition of a network...

NRx Pharmaceutical's (NASDAQ:NRXP) Chairman Dr. Jonathan Javitt to Present at ... - PR Newswire

... Ketamine 2024 Conference, which is planned for March 25-27, 2024, at the Blavatnik School of Government in Oxford, UK. Continue Reading.

NeuroRX

Founder & CEO

Last updated: Jun 26, 2020

Request Deletion